Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biospringer is a global leader in the production of yeast extracts and yeast-derived ingredients, operating as a specialized business unit of the Lesaffre Group. Founded in 1872, the company provides natural origin ingredients that enhance taste and sensory properties in food, while also serving the biotechnology and pharmaceutical industries. Through its Springer Bio-Sciences division, Biospringer supplies high-performance fermentation nutrients, including yeast extracts and peptones, which are essential for the production of vaccines, recombinant proteins, and other biologics. The company maintains a global network of manufacturing facilities and R&D centers to support process optimization and technical innovation for its clients. Their expertise in yeast fermentation and autolysis allows them to offer a wide range of standardized and customized solutions for microbial and cell culture applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biospringer.